- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03041103
Acceptability and Tolerance of a Protein and Micronutrient Fortified Food
Acceptability and Tolerance of a Protein and Micronutrient Fortified Nutritious Food Product in Californian Adults and Children
Study Overview
Detailed Description
Acceptability and tolerance testing will be conducted in 10 healthy male adult volunteers and 10 (40 - 60 years of age), and in children (9-13 years of age). All participants will be asked to consume 50g of a test product every day for 2 weeks for the adult volunteers, while the children will be asked to consume the same product every day for one week. The participants will record amount of daily intake, and will be given an entry and exit surveys. These surveys will include the assessment of potential gastrointestinal changes with daily product intake, and will include questions on how they liked the product. Acceptability will be measured as the number of servings and portion of serving completed each day over the trial period.
In adults only, fasting blood samples and a spot urine will be collected towards preliminary work on potential changes in the metabolome and lipidome with the inclusion of the test product within the habitual diet.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Davis, California, United States, 95616
- Department of Nutrition
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
° Inclusion Criteria:
- Male, 40-60 years old
- Male or Female 9-13 years old
- Subject is willing and able to comply with the study protocols
- Subject is willing to consume the test products
Exclusion Criteria:
- Allergies or intolerances to peas, legumes, pulses, soy, dairy or wheat/gluten
- Under current medical supervision
- Non-English speaking
- Self-reported history of cardiovascular disease, stroke, cancer, renal, hepatic, or thyroid disease, GI tract disorders, previous GI surgery
- Currently taking prescription drugs or supplements
- Daily use of aspirin and or non-steroidal anti-inflammatory medicines.
- Indications of substance or alcohol abuse within the last 3 years
- Any supplement use, including multi-vitamin/ mineral, herbal, plant or botanical, fish oil, and oil supplements.
- Self-reported malabsorption
- Current enrollee in a clinical research study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adult
Food Product 1:50 grams of fortified nutritious product from legumes administered to adults, for 2 weeks
|
50 grams of fortified nutritious product from legumes
|
|
Experimental: Children
Food Product 1: 50 grams of fortified nutritious product from legumes administered to children 9-13 years of age, for 1 weeks
|
50 grams of fortified nutritious product from legumes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
GI function
Time Frame: at 2 weeks
|
GI function questionnaire with categorical numerical score
|
at 2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Carl L Keen, PhD, University of California, Davis
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 985880
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Poor Nutrition
-
Olivia SherWithdrawnPregnancy Related | Nutrition Poor | Nutrition, HealthyUnited States
-
University of Maryland, BaltimoreCompletedPoor NutritionUnited States
-
Inter-American Development BankBusara Center for Behavioral EconomicsNot yet recruiting
-
University of Illinois at Urbana-ChampaignUniversity of Minnesota; The University of The West IndiesCompleted
-
Société des Produits Nestlé (SPN)CompletedNutrition Poor
-
University at AlbanyCompleted
-
University at AlbanyCompletedNutrition Poor
-
Kemin Foods LCDSM Nutritional Products, Inc.Terminated
-
University of California, San FranciscoAmerican Heart Association; Project Open HandCompletedCardiac Rehabilitation | Nutrition Poor | Nutrition, HealthyUnited States
Clinical Trials on Food Product 1
-
Mondelēz International, Inc.TyraTech TechnologyTerminated
-
Harokopio UniversityNational and Kapodistrian University of AthensCompleted
-
Abbott NutritionCompleted
-
Wageningen UniversityCompletedObesity | Overweight | Metabolic Syndrome | Microbiota | Digestion | Small IntestineNetherlands
-
University of Veterinary and Animal Sciences, Lahore...Completed
-
New York State Psychiatric InstituteMars, Inc.CompletedCognitive Function
-
Mondelēz International, Inc.University of Sydney; Glycemic Index Laboratories, Inc; BioFortisCompletedGlycaemia | InsulinemiaAustralia, Canada, France
-
Indonesia UniversityCompletedNutrition PoorIndonesia
-
Amazentis SASGS proderm GmbHCompleted